POINT Biopharma Global
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of POINT Biopharma Global generated cash of $183,518,622, which is more than the previous year. Cash used in financing activities reached the amount of $130,358,744 last year. Net change in cash is therefore $47,612,380.
Cash Flow
| 2019 | 0 | 0 | 0 |
|---|---|---|---|
| 2020 | -8.30M | -9.79M | 28.64M |
| 2021 | -44.69M | -8.80M | 281.77M |
| 2022 | 183.51M | -266.26M | 130.35M |
PNT Cash Flow Statement (2019 – 2022)
| 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|
Cash at beginning of period | 238.81M | 10.54M | 0 | 0 |
Operating activities | ||||
Net income | 98.29M | -45.90M | -13.37M | -36.89K |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||
Depreciation and amortization | 1.39M | 11.84K | 0 | 0 |
Stock-based compensation expense | 3.54M | 2.30M | 1.76M | 0 |
| Deferred income tax benefit | 3.54M | 2.30M | 1.76M | 0 |
| Changes in operating assets and liabilities: | ||||
Accounts receivable, net | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 |
Accounts payable | 4.82M | -2.02M | 3.59M | 0 |
Cash generated by operating activities | 183.51M | -44.69M | -8.30M | 0 |
Investing activities | ||||
Purchases Of Investments | -253.49M | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -12.76M | -8.80M | -9.79M | 0 |
Acquisitions Net | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -266.26M | -8.80M | -9.79M | 0 |
Financing activities | ||||
Common Stock Issued | 130.30M | 264.88M | 25.42M | 0 |
Payments for dividends | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | -3.56M | 0 | 0 |
Cash used in financing activities | 130.35M | 281.77M | 28.64M | 0 |
Net Change In Cash | 47.61M | 228.26M | 10.54M | 0 |
Cash at end of period | 286.42M | 238.81M | 10.54M | 0 |
| Data source | Data source | Data source |